Market overview
The global downstream processing market is worth USD 16.6 bn in 2026 and is forecast to reach USD 45.0 bn by 2036, growing at a 10.5% CAGR. United States is the largest country market and Chromatography is the largest by technique segment.
| Scope | Downstream bioprocessing equipment and consumables for purifying biologics, including chromatography systems and resins, filtration, viral clearance and fill-finish related purification steps. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 15.0 bn |
| Value 2026 | USD 16.6 bn |
| Value 2036 | USD 45.0 bn |
| CAGR 2026-2036 | 10.5% |
| Volume 2026 | 7,111 thousand units |
| Volume 2036 | 17,473 thousand units |
| Average price 2026 | USD 2,331 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Downstream Processing market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 16.6 bn |
| 2027 | USD 18.3 bn |
| 2028 | USD 20.2 bn |
| 2029 | USD 22.4 bn |
| 2030 | USD 24.7 bn |
| 2031 | USD 27.3 bn |
| 2032 | USD 30.2 bn |
| 2033 | USD 33.3 bn |
| 2034 | USD 36.8 bn |
| 2035 | USD 40.7 bn |
| 2036 | USD 45.0 bn |
Downstream Processing market segmentation
By technique
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Chromatography | 40.0% | 38.3% | USD 6.6 bn | 10.0% |
| Filtration | 36.0% | 39.5% | USD 6.0 bn | 11.5% |
| Centrifugation and cell harvest | 12.0% | 9.6% | USD 2.0 bn | 8.0% |
| Viral inactivation and clearance | 12.0% | 12.6% | USD 2.0 bn | 11.0% |
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Consumables and resins | 56.0% | 58.5% | USD 9.3 bn | 11.0% |
| Instruments and systems | 34.0% | 31.0% | USD 5.6 bn | 9.5% |
| Services and software | 10.0% | 10.5% | USD 1.7 bn | 11.0% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Biopharmaceutical companies | 64.0% | 61.7% | USD 10.6 bn | 10.1% |
| Contract manufacturers | 22.0% | 26.5% | USD 3.6 bn | 12.6% |
| Academic and research | 14.0% | 11.8% | USD 2.3 bn | 8.6% |
By process stage
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Capture and harvest | 24.0% | 22.0% | USD 4.0 bn | 9.5% |
| Intermediate purification | 26.0% | 26.0% | USD 4.3 bn | 10.5% |
| Polishing | 20.0% | 21.0% | USD 3.3 bn | 11.0% |
| Ultrafiltration and formulation | 30.0% | 31.0% | USD 5.0 bn | 10.9% |
By molecule type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Monoclonal antibodies | 48.0% | 42.0% | USD 8.0 bn | 9.0% |
| Vaccines | 14.0% | 14.0% | USD 2.3 bn | 10.5% |
| Recombinant proteins | 16.0% | 16.0% | USD 2.7 bn | 10.5% |
| Cell and gene therapies | 12.0% | 20.0% | USD 2.0 bn | 16.3% |
| Other biologics | 10.0% | 8.0% | USD 1.7 bn | 8.1% |
Top 25 countries for downstream processing by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 88.0% of 2026 revenue and the 25 countries below together hold 96.6%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 6.3 bn | 38.0% | USD 16.3 bn | 10.0% |
| 2 | China | USD 1.7 bn | 10.0% | USD 6.1 bn | 13.9% |
| 3 | Germany | USD 1.5 bn | 9.0% | USD 3.7 bn | 9.5% |
| 4 | Switzerland | USD 994 mn | 6.0% | USD 2.6 bn | 9.9% |
| 5 | Japan | USD 829 mn | 5.0% | USD 1.9 bn | 8.8% |
| 6 | Ireland | USD 829 mn | 5.0% | USD 2.2 bn | 10.1% |
| 7 | United Kingdom | USD 663 mn | 4.0% | USD 1.6 bn | 9.3% |
| 8 | South Korea | USD 663 mn | 4.0% | USD 2.1 bn | 12.1% |
| 9 | Singapore | USD 663 mn | 4.0% | USD 1.9 bn | 11.0% |
| 10 | Denmark | USD 497 mn | 3.0% | USD 1.3 bn | 10.1% |
| 11 | India | USD 220 mn | 1.3% | USD 720 mn | 12.6% |
| 12 | France | USD 141 mn | 0.8% | USD 369 mn | 10.1% |
| 13 | Belgium | USD 126 mn | 0.8% | USD 328 mn | 10.1% |
| 14 | Netherlands | USD 109 mn | 0.7% | USD 288 mn | 10.2% |
| 15 | Canada | USD 109 mn | 0.7% | USD 288 mn | 10.2% |
| 16 | Italy | USD 94 mn | 0.6% | USD 247 mn | 10.1% |
| 17 | Sweden | USD 94 mn | 0.6% | USD 247 mn | 10.1% |
| 18 | Spain | USD 78 mn | 0.5% | USD 207 mn | 10.3% |
| 19 | Australia | USD 78 mn | 0.5% | USD 207 mn | 10.3% |
| 20 | Brazil | USD 78 mn | 0.5% | USD 256 mn | 12.7% |
| 21 | Taiwan | USD 78 mn | 0.5% | USD 207 mn | 10.3% |
| 22 | Austria | USD 63 mn | 0.4% | USD 166 mn | 10.2% |
| 23 | Israel | USD 63 mn | 0.4% | USD 166 mn | 10.2% |
| 24 | Norway | USD 46 mn | 0.3% | USD 121 mn | 10.1% |
| 25 | Finland | USD 46 mn | 0.3% | USD 121 mn | 10.1% |
| Rest of world | USD 564 mn | 3.4% | USD 1.4 bn | 9.6% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Cytiva
- Sartorius
- Merck KGaA
- Thermo Fisher Scientific
- Repligen
- Danaher
- GEA Group
- Alfa Laval
Group 2: Regional and specialist players
- Bio-Rad Laboratories
- Tosoh Bioscience
- Avantor
- Meissner Filtration Products
- Knauer
- Parker Hannifin
- Mitsubishi Chemical
Group 3: Emerging and niche players
- Purolite
- Asahi Kasei
- Novasep
- Bio-Works
- Astrea Bioseparations
- Cobetter Filtration
- PendoTech
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the downstream processing market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 10.5% is calculated from the resulting values.
The market is divided by technique, by product, by end user, by process stage, by molecule type. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the downstream processing market?
The global downstream processing market is estimated at USD 15.0 bn in 2025 and USD 16.6 bn in 2026.
How fast will the downstream processing market grow?
It is forecast to reach USD 45.0 bn by 2036, a compound annual growth rate of 10.5% from 2026, an increase of USD 28.4 bn.
Which country is the largest market for downstream processing?
United States is the largest market by revenue at USD 6.3 bn in 2026, 38.0% of the global total. The three largest countries together hold 57.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 13.9% a year from 2026 to 2036.
Which downstream processing segment is largest?
In the by technique split, Chromatography is the largest segment with 40.0% of 2026 revenue.
Who are the leading downstream processing companies?
Global leaders include Cytiva, Sartorius, Merck KGaA, Thermo Fisher Scientific.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Antibody Drug ConjugatesUSD 16.5 bn · 14.5% CAGR
- Next Generation SequencingUSD 16.4 bn · 13.0% CAGR
- Insulin DeliveryUSD 16.8 bn · 8.0% CAGR
- Rare Cardiovascular Disease TherapeuticsUSD 16.1 bn · 9.0% CAGR
- Pharmaceutical FiltrationUSD 15.8 bn · 9.0% CAGR
- Fill FinishUSD 17.6 bn · 9.0% CAGR
- Surgical RoboticsUSD 17.7 bn · 14.0% CAGR
- Metered Dose InhalerUSD 17.9 bn · 5.0% CAGR